Product Details
TRIUMEQ
Dolutegravir (Dolutegravir Sodium); Abacavir; Lamivudine50 mg; 600 mg; 300 mg
Tablet
ROA
Oral
Applicant Name
GlaxoSmithKline Pharmaceutical Nig. PLC (GSK)
NRN
B4-8285
Status
Active
ATC Code
J05AR13
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1*30tablets
Product Description
TRIUMEQ DOLUTEGRAVIR/ABACAVIR/LAMIVUDINE 50 mg of dolutegravir as dolutegravir sodium, 600 mg of abacavir as abacavir sulfate and 300 mg of lamivudine B4-8285 Drugs Imported Products 1*30tablets POM 1 30/01/2023 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD., INDUSTRIAL AVENUE ILUPEJU LAGOS 12711000 delphine.u.onyeaso@gsk.com GLAXO OPERATIONS UK LTD , PRIORY STREET ,WARE HERTFORDSHIRE SG12 0DJ, UNITED KINGDOM . , GLAXO OPERATIONS UK LTD , PRIORY STREET ,WARE HERTFORDSHIRE SG12 0DJ, UNITED KINGDOM . , United Kingdom
Manufacturer Name
Glaxo Operations UK Limited
Manufacturer Country
UNITED KINGDOM
Approval Date
2023-04-26
Expiry Date
2028-04-25